MARKET

HALO

HALO

Halozyme Thrp
NASDAQ
57.15
-0.48
-0.83%
After Hours: 57.15 0 0.00% 18:23 07/11 EDT
OPEN
57.37
PREV CLOSE
57.63
HIGH
57.86
LOW
56.79
VOLUME
1.24M
TURNOVER
--
52 WEEK HIGH
70.51
52 WEEK LOW
42.01
MARKET CAP
7.04B
P/E (TTM)
15.17
1D
5D
1M
3M
1Y
5Y
1D
Should Invesco S&P MidCap 400 GARP ETF (GRPM) Be on Your Investing Radar?
NASDAQ · 17h ago
Helen Torley, President and CEO, Reports Disposal of Common Shares in Halozyme Therapeutics Inc
Reuters · 1d ago
Halozyme (HALO) Gets a Hold from Goldman Sachs
TipRanks · 1d ago
Halozyme resumed with a Neutral at Goldman Sachs
TipRanks · 1d ago
Halozyme Therapeutics (HALO) Shares Cross Above 200 DMA
NASDAQ · 3d ago
Here's How Much You Would Have Made Owning Halozyme Therapeutics Stock In The Last 15 Years
Benzinga · 4d ago
Weekly Report: what happened at HALO last week (0630-0704)?
Weekly Report · 4d ago
NYLI MacKay Convertible Fund Q1 2025 Commentary
Seeking Alpha · 5d ago
More
About HALO
Halozyme Therapeutics, Inc. is a biopharmaceutical company advancing solutions to improve patient experiences and outcomes for emerging and established therapies. The Company's commercially-validated solution, ENHANZE drug delivery technology with the proprietary enzyme rHuPH20, is used to facilitate the subcutaneous delivery of injected drugs and fluids, with a focus on improving the patient experience with rapid subcutaneous delivery and reduced treatment burden. The Company licenses its technology to biopharmaceutical companies to collaboratively develop products that combine ENHANZE with its partners’ proprietary compounds. It also develops, manufactures and commercializes, for itself or with partners, drug-device combination products using its advanced auto-injector technologies. The Company has two commercial proprietary products, Hylenex and XYOSTED, partnered commercial products and ongoing product development programs with Teva Pharmaceuticals and Idorsia Pharmaceuticals.

Webull offers Halozyme Therapeutics, Inc. stock information, including NASDAQ: HALO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HALO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HALO stock methods without spending real money on the virtual paper trading platform.